GSK “Open Innovation Agenda,” Possible Malaria Vaccine
CEO Andrew Witty of UK pharmaceutical manufacturer GlaxoSmithKline today announced the launch of an agenda on “open innovation,” through which it promises increased flexibility over its intellectual property as well as partnerships in which its facilities, infrastructure, and actual chemical…
